- •Influenza vaccination can reduce hospitalization rates by approximately 40% for those individuals deemed to be at high risk.
- •Pneumococcal vaccination is desired in people with diabetes as they are considered as likely to be infected as those with other chronic diseases.
- •Adults with type 1 and type 2 diabetes are at higher risk of hepatitis B virus infection.
- •You should receive routine vaccinations as recommended for anyone with or without diabetes. Check if you are up to date with your vaccinations.
- •You should receive:
- ◦Influenza vaccination(“flu shot”) every year
- ◦Pneumococcal vaccination:
- ■Initially, when you are over the age of 18 years
- ■And, again, when you are over the age of 65 years (if your original vaccination was given when you were younger than 65 years and your last vaccination was over 5 years ago)
Influenza Vaccination in Adults
Pneumococcal Vaccination in Adults
- Government of Canada
Hepatitis B Vaccination
Hepatitis B and Diabetes
- Government of Canada
Herpes Zoster and Diabetes
- An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
- •Routinely recommend for adults ≥60 years of age.
- •Vaccination before 60 years of age might not have the required protection when the risks and complications of herpes zoster are highest (i.e. ≥60 years of age).
- •Protection offered by the herpes zoster vaccine wanes within the first 5 years (36).
- •Beyond 5 years of vaccination, duration of protection is uncertain.
- •Immunocompromised individuals are an important group to consider when discussing vaccinations, such as herpes zoster vaccine.
- 1.People with diabetes should receive routine vaccination as recommended for the general population in keeping with the National Advisory Committee on Immunization guidelines [Grade D, Consensus] (available at http://www.phac-aspc.gc.ca/publicat/cig-gci/index-eng.php).
- 2.People with diabetes should receive an annual influenza vaccination during flu season to reduce the risk of influenza-related hospitalizations and death [Grade C, Level 3 (5)].
- 3.Pneu-P-23 vaccination should be offered to persons with diabetes aged 19 to 64 years. A 1-time revaccination is recommended for those ≥65 years of age (if the original vaccine was given when they were <65 years of age). For people with diabetes ≥65 years or with an immunocompromising condition (e.g. end stage renal disease), Pneu-C-13 vaccine should be administered first, followed at least 8 weeks later by Pneu-P-23 vaccine. In people who have already received Pneu-P-23, at least 1 year should elapse before they are given Pneu-C-13 [Grade D, Consensus].
- National Advisory Committee on Immunization. Canadian Immunization Guide. 7th edn. Ottawa: Canadian Medical Association, 2016. Available at: http://www.phac-aspc.gc.ca/publicat/cig-gci/index-eng.php. Accessed April 25, 2016.
- Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus.Clin Infect Dis. 2005; 41: 281-288
- Impact of influenza vaccination on mortality risk among the elderly.Eur Respir J. 2009; 34: 56-62
- Hospitalized patients with 2009 H1N1 influenza in the United States, April–June 2009.N Engl J Med. 2009; 361: 1935-1944
- Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza.CMAJ. 2010; 182: 349-355
- Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes.CMAJ. 2016; 188: E342-E351
- Diabetes and the severity of pandemic influenza A (H1N1) infection.Diabetes Care. 2010; 33: 1491-1493
- Working-age adults with diabetes experience greater susceptibility to seasonal influenza: A population-based cohort study.Diabetologia. 2014; 57: 690-698
- Effectiveness of influenza vaccine in the community-dwelling elderly.N Engl J Med. 2007; 357: 1373-1381
- Effectiveness of influenza vaccination in elderly diabetic patients: A retrospective cohort study.Vaccine. 2013; 31: 718-724
- Effectiveness of influenza vaccination in working-age adults with diabetes: A population-based cohort study.Thorax. 2013; 68: 658-663
- Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients.Diabetes Care. 2006; 29: 1771-1776
- Diabetes, glycemic control, and risk of hospitalization with pneumonia: A population-based case-control study.Diabetes Care. 2008; 31: 1541-1545
- Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia.Clin Infect Dis. 2006; 42: 1093-1101
- Canadian immunization guide: Part 4—active vaccines.Public Health Agency of Canada, Toronto (ON)2016https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines.html?(Accessed November 15, 2017)
- Intervals between PCV13 and PPSV23 vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Morb Mortal Wkly Rep. 2015; 64: 944-947
- Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).MMWR Morb Mortal Wkly Rep. 2010; 59: 1102-1106
- Epidemiology of HCC: Consider the population.J Clin Gastroenterol. 2013; 47: S2-S6
- The global health burden of infection-associated cancers in the year 2002.Int J Cancer. 2006; 118: 3030-3044
- Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.N Engl J Med. 1997; 336: 1855-1859
- Increased risk of acute hepatitis B among adults with diagnosed diabetes mellitus.J Diabetes Sci Technol. 2012; 6: 858-866
- Evaluation of the potential for bloodborne pathogen transmission associated with diabetes care practices in nursing homes and assisted living facilities, Pinellas County.J Am Geriatr Soc. 2010; 58: 914-918
- “Never events”: Hepatitis B outbreaks and patient notifications resulting from unsafe practices during assisted monitoring of blood glucose, 2009–2010.J Diabetes Sci Technol. 2011; 5: 1396-1402
- Viral hepatitis transmission in ambulatory health care settings.Clin Infect Dis. 2004; 38: 1592-1598
- Transmission of hepatitis B virus among persons undergoing blood glucose monitoring in long-term–care facilities—Mississippi, North Carolina, and Los Angeles County, California, 2003–2004.MMWR Morb Mortal Wkly Rep. 2005; 54: 220-223
- Use of hepatitis B vaccination for adults with diabetes mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Morb Mortal Wkly Rep. 2011; 60: 1709-1711
- Clinical practice. Herpes zoster.N Engl J Med. 2002; 347: 340-346
- Risk of herpes zoster among diabetics: A matched cohort study in a US insurance claim database before introduction of vaccination, 1997–2006.Infection. 2014; 42: 729-735
- Vaccines for preventing herpes zoster in older adults.Sao Paulo Med J. 2014; 132: 255
- Increased risk of herpes zoster in diabetic patients comorbid with coronary artery disease and microvascular disorders: A population-based study in Taiwan.PLoS ONE. 2016; 11: e0146750
- Safety and effectiveness of the herpes zoster vaccine to prevent postherpetic neuralgia: 2014 update and consensus statement from the Canadian Pain Society.Pain Res Manag. 2015; 20: 46-47
- Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections.Diabete Metab. 1992; 18: 187-201
- Diabetes as a risk factor for herpes zoster infection: Results of a population-based study in Israel.Infection. 2008; 36: 226-230
- Comparison of varicella-zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals.J Infect Dis. 2009; 200: 1606-1610
- Update on recommendations for use of herpes zoster vaccine.MMWR Morb Mortal Wkly Rep. 2014; 63: 729-731
- Update on the use of herpes zoster vaccine.Public Health Agency of Canada, Toronto2014https://www.canada.ca/en/public-health/services/publications/healthy-living/update-use-herpes-zoster-vaccine.html(Accessed November 15, 2017)
- Vaccines for preventing herpes zoster in older adults.Cochrane Database Syst Rev. 2016; (CD008858)
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement.PLoS Med. 2009; 6 (e1000097)
The Canadian Diabetes Association is the registered owner of the name Diabetes Canada.
Conflict of interest statements can be found on page S144.